Difference between revisions of "Healthcare AI Use Cases"

From PatientRecovery
Jump to: navigation, search
 
Line 1: Line 1:
 
==ClosedLoop AI Use Cases==
 
==ClosedLoop AI Use Cases==
Hospitals <br>
 
* [https://news.mit.edu/2020/closedloop-ai-predictive-health-care-0619?utm_source=miragenews&utm_medium=miragenews&utm_campaign=news '''Appointment No-Shows''' - Predict patients most likely to miss appointments]
 
* [https://news.mit.edu/2020/closedloop-ai-predictive-health-care-0619?utm_source=miragenews&utm_medium=miragenews&utm_campaign=news Predict patients most likely to acquire infections like sepsis]
 
* [https://news.mit.edu/2020/closedloop-ai-predictive-health-care-0619?utm_source=miragenews&utm_medium=miragenews&utm_campaign=news Predict patients most likely to benefit from periodic check ups]
 
* Leakage - Network Integrity - Out of Network
 
*
 
Health Insurers <br>
 
* Risk Adjustment - Suspect Diagnosis
 
* [https://closedloop.ai/preventable-hospitalizations/ Preventable Hospitalizations]
 
* [https://closedloop.ai/readmissions/ Readmissions] - [https://news.mit.edu/2020/closedloop-ai-predictive-health-care-0619?utm_source=miragenews&utm_medium=miragenews&utm_campaign=news Predict patient readmissions]
 
* [https://closedloop.ai/chronic-disease/ Chronic Disease Onset and Progression] - [https://news.mit.edu/2020/closedloop-ai-predictive-health-care-0619?utm_source=miragenews&utm_medium=miragenews&utm_campaign=news Predict onset or progression of chronic diseases.]
 
* [https://closedloop.ai/total-risk/ Patients with highest overall risk in the next 6 months or year]
 
 
 
 
Providers & ACOs <br>
 
Providers & ACOs <br>
 
* [https://news.mit.edu/2020/closedloop-ai-predictive-health-care-0619?utm_source=miragenews&utm_medium=miragenews&utm_campaign=news '''Appointment No-Shows''' - Predict patients most likely to miss appointments]
 
* [https://news.mit.edu/2020/closedloop-ai-predictive-health-care-0619?utm_source=miragenews&utm_medium=miragenews&utm_campaign=news '''Appointment No-Shows''' - Predict patients most likely to miss appointments]
Line 28: Line 14:
  
 
Payers and Health Plans <br>
 
Payers and Health Plans <br>
 +
* Risk Adjustment - Suspect Diagnosis
 +
* [https://closedloop.ai/preventable-hospitalizations/ Preventable Hospitalizations]
 +
* [https://closedloop.ai/readmissions/ Readmissions] - [https://news.mit.edu/2020/closedloop-ai-predictive-health-care-0619?utm_source=miragenews&utm_medium=miragenews&utm_campaign=news Predict patient readmissions]
 +
* [https://closedloop.ai/chronic-disease/ Chronic Disease Onset and Progression] - [https://news.mit.edu/2020/closedloop-ai-predictive-health-care-0619?utm_source=miragenews&utm_medium=miragenews&utm_campaign=news Predict onset or progression of chronic diseases.]
 +
* [https://closedloop.ai/total-risk/ Patients with highest overall risk in the next 6 months or year]
 
* Trend:  Which members are likely to see large increases in their overall health risk over the next three to six months?
 
* Trend:  Which members are likely to see large increases in their overall health risk over the next three to six months?
 
* Readmissions:  Which members are most likely to be readmitted to the hospital?
 
* Readmissions:  Which members are most likely to be readmitted to the hospital?

Latest revision as of 11:27, 10 July 2020

ClosedLoop AI Use Cases

Providers & ACOs

Payers and Health Plans

Pharma & Life Science

  • Biomarkers: Which patients will have an increased success rate based on biological factors?
  • Drug-Combinations: Which drug combinations are most likely to be successful?
  • Segmentation: Which groups of patients respond differently to treatment?
  • Strategy: Which subpopulations should be included/excluded based off of predicted success rates?
  • Responsive: Which patients are responding to treatment?
  • Events: Which patients are most likely to experience adverse reactions?
  • Effectiveness: How will clinical trial results translate into real world effectiveness?
  • Value: What improvement in outcomes will a new treatment generate over existing therapies?
  • Switching: Which factors are most relevant in understanding which patients switch drugs?
  • Marketing: Which physicians can we market to?


Other